Summary
- Current Price
- As of today, GH price is $103.10, down -3.08% on
- Current Price All-Time High
- GH price is currently -43.06% below its historical high of $181.07 set on
- Market Cap
- GH current market cap is $13B, up +128.88% over the past 365 days
- PE Ratio
- GH PE ratio is unknown
- Revenue
- GH current annual revenue is $739.02M, up +31.04% year-over-year
- Next Earnings
- The next earnings release for GH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Guardant Health, Inc. |
| Ticker | NASDAQ: GH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | guardanthealth.com |
| Employees | 1,999 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $103.10 | |
| Price, 1D Change | -3.08% | |
| Market Cap | $13B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.02 | |
| Revenue | $739M | |
| Revenue, 1Y Change | +31.04% | |
| EPS | -$3.56 | |
| EPS, 1Y Change | +16.96% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$3.56 | |
| EPS Estimate | -$1.81 | |
| EPS Est. Change | +49.21% | |
| Revenue | $739.02M | |
| Revenue Estimate | $972.05M | |
| Revenue Est. Change | +31.53% | |
| Current Price | $103.10 | |
| Price Target | - | $130.00 |
| Price Tgt. Change | - | +26.09% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.99 | -$3.56 | -78.95% | |
| -$1.81 | N/A | +49.21% | |
| -$1.59 | N/A | +55.38% | |
| -$0.66 | N/A | +81.56% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $729.04M | $739.02M | +1.37% | |
| $972.05M | N/A | +31.53% | |
| $1.27B | N/A | +71.80% | |
| $1.61B | N/A | +118.49% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +117.51% | |
| Price, 3Y | +262.39% | |
| Market Cap, 1Y | +128.88% | |
| Market Cap, 3Y | +358.44% | |
| Revenue, 1Y | +31.04% | |
| Revenue, 3Y | +97.78% | |
| EPS, 1Y | +16.96% | |
| EPS, 3Y | +11.21% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $103.10 | |
| SMA 200 | $73.03 | |
| SMA 200 vs Price | -29.16% | |
| SMA 50 | $106.43 | |
| SMA 50 vs Price | +3.23% | |
| Beta | 1.02 | |
| ATR | $6.29 | |
| 14-Day RSI | 43.93 | |
| 10-Day Volatility | 43.36% | |
| 1-Year Volatility | 62.12% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $739.02M | |
| EPS | -$3.56 | |
| Gross Profit | $449.22M | |
| Gross Margin | 60.79% | |
| Operating Profit | -$443.59M | |
| Operating Margin | -60.03% | |
| Net Income | -$436.37M | |
| Net Margin | -59.05% | |
| EBITDA | -$390.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -8.18 | |
| 4.68 | ||
| 4.36 | ||
| -167.57 | ||
| 4 | ||
| 2.72 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 14.84 | ||
| -37.77 | ||
| -35.14 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$139.65M | |
| $525.54M | ||
| $1.49B | ||
| $1.06B | ||
| $1.63B | ||
| $225.58M | ||
| Total Debt | $1.34B | |
| $29.21M | ||
| $38.55M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.18B | ||
| $892.81M | ||
| $289.80M | ||
| $545.06M | ||
| $42.39M | ||
| $2.58M | ||
| $1.28M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$239.86M | ||
| -$261.31M | ||
| -$996.00K | ||
| Capex | $35.09M | |
| -$274.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| TD Cowen | → | |
| Stifel | → | |
| Leerink Partners | → | |
| JP Morgan | → | |
| Evercore ISI Group | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| BTIG | → | |
| Baird |
Analyst sentiment
Institutional ownership
Screeners with GH
FAQ
What is the ticker symbol for Guardant Health, Inc.?
The ticker symbol for Guardant Health, Inc. is NASDAQ:GH
Does Guardant Health, Inc. pay dividends?
No, Guardant Health, Inc. does not pay dividends
What sector is Guardant Health, Inc. in?
Guardant Health, Inc. is in the Healthcare sector
What industry is Guardant Health, Inc. in?
Guardant Health, Inc. is in the Diagnostics & Research industry
What country is Guardant Health, Inc. based in?
Guardant Health, Inc. is headquartered in United States
When did Guardant Health, Inc. go public?
Guardant Health, Inc. initial public offering (IPO) was on October 4, 2018
Is Guardant Health, Inc. in the S&P 500?
No, Guardant Health, Inc. is not included in the S&P 500 index
Is Guardant Health, Inc. in the NASDAQ 100?
No, Guardant Health, Inc. is not included in the NASDAQ 100 index
Is Guardant Health, Inc. in the Dow Jones?
No, Guardant Health, Inc. is not included in the Dow Jones index
When was Guardant Health, Inc. last earnings report?
Guardant Health, Inc.'s most recent earnings report was on February 19, 2026
When does Guardant Health, Inc. report earnings?
The next expected earnings date for Guardant Health, Inc. is April 29, 2026
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1576280/000157628025000277/0001576280-25-000277-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628025000044/0001576280-25-000044-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh